TY - JOUR
T1 - Intraoperative radiation therapy in the multimodality approach to hepatobiliary tract cancer
AU - Thomas, Charles R.
AU - Merrick, Hollis W.
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2003/10
Y1 - 2003/10
N2 - IOERT is a reasonable option to consider in patients who have biliary tract cancers above AJCC or Bismuth stage I disease. Inherent resistance of biliary tract cancer cells to ionizing radiation would indicate that IOERT alone would not eradicate most of the tumor clonagen. EBRT (either preoperatively or postoperatively) should be used in combination with IOERT at experienced institutions that have access to both modalities. The single IOERT dose ranges are 10 to 20 Gy [55,67], whereas the EBRT dose ranges from 45 to 50 Gy in 25 to 28 fractions [67]. The most common energy level used is 8 MeV or less. In addition, IOERT port sizes of less than 6 cm in diameter, and often 4 cm or less, are recommended. Finally, intraoperative reconstruction of severely damaged blood vessels may decrease the clinical manifestation of radiation-induced injury to vessels [68].
AB - IOERT is a reasonable option to consider in patients who have biliary tract cancers above AJCC or Bismuth stage I disease. Inherent resistance of biliary tract cancer cells to ionizing radiation would indicate that IOERT alone would not eradicate most of the tumor clonagen. EBRT (either preoperatively or postoperatively) should be used in combination with IOERT at experienced institutions that have access to both modalities. The single IOERT dose ranges are 10 to 20 Gy [55,67], whereas the EBRT dose ranges from 45 to 50 Gy in 25 to 28 fractions [67]. The most common energy level used is 8 MeV or less. In addition, IOERT port sizes of less than 6 cm in diameter, and often 4 cm or less, are recommended. Finally, intraoperative reconstruction of severely damaged blood vessels may decrease the clinical manifestation of radiation-induced injury to vessels [68].
UR - http://www.scopus.com/inward/record.url?scp=0345017861&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0345017861&partnerID=8YFLogxK
U2 - 10.1016/S1055-3207(03)00085-1
DO - 10.1016/S1055-3207(03)00085-1
M3 - Review article
C2 - 14989128
AN - SCOPUS:0345017861
SN - 1055-3207
VL - 12
SP - 979
EP - 992
JO - Surgical Oncology Clinics of North America
JF - Surgical Oncology Clinics of North America
IS - 4
ER -